RxDoctor Payments DataLook up a doctor →

Sherry Aleksich, NP

Psychiatric/Mental Health · Milwaukee, WINPI 1114173523

Payments from drug & device makers

$33,398in general payments, 2019–2025

Across 627 payments — averaging $53.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$24K
  • Corium, LLC$941
  • Otsuka America Pharmaceutical, Inc.$895
  • Lundbeck LLC$809
  • Neurocrine Biosciences, Inc.$784
  • Axsome Therapeutics, Inc.$587
  • plus $5K from 32 others

What the payments were for

  • Speaking & faculty fees$19,77559%
  • Travel & lodging$1,1814%
  • Food & beverage$12,42237%
  • Education$200%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie202$23,962
Corium, LLC46$941
Otsuka America Pharmaceutical, Inc.28$895
Lundbeck LLC44$809
Neurocrine Biosciences, Inc.24$784
Axsome Therapeutics, Inc.24$587
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)30$583
Alkermes, Inc.22$541
Harmony Biosciences LLC36$531
Supernus Pharmaceuticals, Inc.31$526
Takeda Pharmaceuticals U.S.A., Inc.20$451
Johnson & Johnson8$303
Tris Pharma Inc16$294
Pfizer15$274
Teva Pharmaceuticals USA, Inc.14$267
Biohaven Pharmaceuticals, Inc.6$250
Bausch Health US, LLC14$219
SK Life Science, Inc.3$191
UCB, Inc.5$142
Biohaven Pharmaceutical Holding Company Ltd.6$135
Jazz Pharmaceuticals Inc.5$117
Ironshore Pharmaceuticals Inc.5$111
Neos Therapeutics, LP4$84
E.r. Squibb & Sons, L.L.C.2$55
Adlon Therapeutics L.p.2$37
Lilly USA, LLC2$37
Avanir Pharmaceuticals, Inc.1$35
Idorsia Pharmaceuticals US Inc2$34
Amgen1$28
Vanda Pharmaceuticals Inc.1$27
Collegium Pharmaceutical, Inc.1$21
Acadia Pharmaceuticals Inc1$21
OWP Pharmaceuticals, Inc.1$20
Tempus AI, Inc1$18
Impel Pharmaceuticals Inc.1$18
Vertical Pharmaceuticals, LLC1$17
Upsher-smith Laboratories LLC1$17
Livanova USA, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,398 in reported general payments places this provider in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.

See all psychiatric/mental health providers in Wisconsin →

Medicare billing

Part B allowed, 2024
$4,677
Medicare patients
22
Services billed
42

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naltrexone Hcl11$2,355
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine18$477
Gabapentin11$399
Alprazolam17$134
Trazodone Hcl14$128
Sertraline Hcl12$52

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Milwaukee

See the full list for Wisconsin →

Where these figures come from

Is this you, or does something look wrong? →